Results 91 to 100 of about 10,185,878 (314)

Memories of the medical faculty

Kazan medical journal, 1994
In August 1919, I came to Kazan from the wilderness of the Penza province (b. Chembarsky district, now Belinsky district of the Penza region, 50 km from the railway station), because in the spring of that year I applied to Kazan University with a request to enroll me in the mathematical department of physics. For admission to students, it was enough to
openaire   +1 more source

Minutes: Medical School Faculty Assembly, May 16, 2005

, 2005
University of Minnesota. Medical School Faculty Assembly. (2005). Minutes: Medical School Faculty Assembly, May 16, 2005.
University of Minnesota. Medical School Faculty Assembly
core  

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

Minutes: Medical School Faculty Assembly, May 23, 2007

, 2007
University of Minnesota. Medical School Faculty Assembly. (2007). Minutes: Medical School Faculty Assembly, May 23, 2007.
University of Minnesota. Medical School Faculty Assembly
core  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Awareness of periodontal disease and its management among medical faculty in Guntur district: A questionnaire-based study

Journal of Indian Society of Periodontology, 2016
Aim: The aim of this study was to assess the awareness of periodontal disease, its influence on general health, and attitude toward periodontal disease management among medical faculty in Guntur district.
Ravindranath Dhulipalla, Yamuna Marella, Alluri Juhee Keerthana, Harish Prabhu Dev Pillutla, Chaitanya Chintagunta, Tejaswin Polepalle   +5 more
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Minutes: Medical School Faculty Assembly, November 17, 2008

, 2008
University of Minnesota. Medical School Faculty Assembly. (2008). Minutes: Medical School Faculty Assembly, November 17, 2008.
University of Minnesota. Medical School Faculty Assembly
core  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Minutes: Medical School Faculty Assembly, October 16, 2006

, 2006
University of Minnesota. Medical School Faculty Assembly. (2006). Minutes: Medical School Faculty Assembly, October 16, 2006.
University of Minnesota. Medical School Faculty Assembly
core